TIMESSQUARE CAPITAL MANAGEMENT, LLC Intra-Cellular Therapies, Inc. Transaction History

TIMESSQUARE CAPITAL MANAGEMENT, LLC portfolio value:

$41.20M
portfolio value

TIMESSQUARE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +10.57% 84.67K shares -4.50M $46.53 885.51K
Q2 2022 share Decrease -8.69% -76.19K shares -7.95M $57.08 800.83K
Q1 2022 share Decrease -34.74% -466.93K shares -16.67M $61.19 877.02K
Q4 2021 share Decrease -21.80% -374.7K shares 6.27M $52.13 1.34M
Q3 2021 share Increase +49.01% 565.28K shares 16.99M $37.28 1.71M
Q2 2021 share Decrease -6.02% -73.9K shares 5.43M $40.82 1.15M
Q1 2021 share Increase +38.02% 338.08K shares 13.36M $33.93 1.22M
Q4 2020 share Decrease -1.47% -13.3K shares 5.11M $31.8 889.2K
Q3 2020 share Increase 0.00% 902.5K shares 23.15M $25.66 902.5K
Q1 2017 share Decrease -100.00% -1.53M shares -23.16M $16.25 0
Q4 2016 share Decrease -12.62% -221.63K shares -3.60M $15.09 1.53M
Q3 2016 share Increase +8.44% 136.7K shares -36.11M $15.24 1.75M
Q2 2016 share Increase +6.26% 95.5K shares 20.50M $38.82 1.61M
Q1 2016 share Increase +15.62% 205.95K shares -28.54M $27.8 1.52M